SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Nureca has informed it enclosed disclosure received from Nectar Biopharma, Member of Promoter Group pursuant to Regulation 7(2) of PIT Regulations in respect of disposal of shares of the company through an off-market transaction. The disclosure is not required vide SEBI Circular No. SEBI/HO/ISD/ISD/CIR/P/2020/168 and SEBI/HO/ISD/ISD/CIR/P/2021/617 dated September 09, 2020 and August 13, 2021 respectively.

The above information is a part of company’s filings submitted to BSE.  

Nureca Ltd. Share Price

227.20 -5.40 (-2.32%)
10-Jun-2026 16:01 View Price Chart
Peers
Company Name CMP
Lenskart Solutions 500.65
Poly Medicure 1415.00
Laxmi Denta 218.75
Nureca Ltd. 227.20
Hemant Surgical Inds 381.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×